
    
      TREATMENT/FOLLOW-UP:

      Participants meeting eligibility criteria will receive open label nitric oxide at 80 ppm via
      a nasal cannula. Hemodynamic clinical laboratory and clinical assessment data will be
      collected at baseline, after 15 minutes of inhaled nitric oxide administration, post RHC
      procedure and at hospital discharge. Day 5 +/- 3 post RHC, telephone contact to assess
      general health status.
    
  